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 PREVALENS JANGKITAN PENYAKIT BAWAAN VEKTOR  
DI HOSPITAL TAMPIN, NEGERI SEMBILAN 
 
 
 
ABSTRAK 
 
 
 Penyakit bawaan vektor adalah dianggap sangat penting dan telah banyak 
memberi kesan kepada kesihatan manusia dan juga haiwan. Pada tahun 1877, 
limfatik filariasis merupakan penyakit bawaan vektor yang pertama dikenalpasti 
disebabkan nyamuk  yang merebak dari manusia ke manusia.  Malaysia 
merupakan negara subtropika yang  sering dijangkiti pelbagai penyakit bawaan 
vektor yang dibawa oleh nyamuk seperti malaria, denggi, filariasis, dan ensefalitis. 
Penyakit bawaan vektor seperti malaria, filariasis, dan denggi menyebabkan  
morbiditi dan kematian di negara-negara tropika, termasuk Malaysia. Maka, 
penyakit bawaan vektor ini menjadi tumpuan utama penyelidikan dan pengurusan 
alam sekitar di Malaysia , terutamanya di Hospital Tampin yang menunjukkan 
penyakit malaria dan denggi dilaporkan meningkat  setiap tahun.  Dalam kajian ini, 
data yang dikumpul dari tahun 2012 hingga 2014 menunjukkan jumlah kes denggi 
dilaporkan paling tinggi di daerah Tampin iaitu seramai 199 pesakit telah 
dilaporkan menghidap penyakit denggi.  Ujian molekul (PCR) telah dijalankan 
terhadap virus denggi, didapati seramai 73 pesakit iaitu 21 pesakit (2012), 31 
pesakit (2013) dan 21 pesakit (2014) yang tinggal di mukim-mukim, Daerah 
Tampin, Negeri Sembilan telah dijangkiti virus denggi serotaip 4 (DENV 4). Tiada 
kes denggi yang disebabkan oleh serotaip DENV 1, DENV 2 dan DENV 3 yang 
dilaporkan dalam kajian ini,  kemungkinan ianya disebabkan oleh faktor-faktor 
 xix   
 
seperti kestabilan virus dan kualiti sampel yang diambil dari pesakit dari segi 
penyimpanan dan juga masa penghantaran sampel ke makmal. Malaria dan 
filariasis tidak dilaporkan di Hospital Tampin semasa kajian ini dijalankan.  
Namun, sampel filem darah masih diambil di kalangan  pesakit bagi menjalani 
ujian pemeriksaan mikroskopik sebelum ujian PCR dilakukan.   Walaubagaiman 
pun,  tiada inciden kes malaria dan filariasis dilaporkan sepanjang 3 tahun kajian 
kecuali tiga (3) pesakit telah dilaporkan positif  dengan jangkitan malaria dan 
spesis yang dikenalpasti adalah  Plasmodium knowlesi.  Pesakit-pesakit yang 
dikenalpasti positif dengan ujian malaria adalah berasal dari Hutan Percha, Alor 
Gajah, Melaka (pesakit 1lelaki) dan Johol, Kuala Pilah, Negeri Sembilan (1 lelaki 
dan 1 perempuan).  
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THE PREVALENCE OF VECTOR BORNE DISEASES 
IN TAMPIN HOSPITAL, NEGERI SEMBILAN 
 
 
ABSTRACT 
 
Vector-borne diseases are considered important diseases and have greatly 
impact on the health of humans and animals as well.  It was first described in 1877 
when lymphatic filariasis was found to be transmitted by mosquitoes from human 
to human.  Malaysia lies in a tropical zone, and often invaded by various vector 
borne diseases especially mosquitoes which are capable of transmitting diseases 
like malaria, dengue, filariasis, and Japanese encaphalitis.  Vector borne diseases 
like malaria, filariasis, and dengue are still responsible for the high incidence of 
morbidity and mortality in many tropical countries, including Malaysia.  
Therefore, the vector-borne diseases caused by mosquitoes remain as the main 
focus of research and environmental management in Malaysia especially in 
Tampin Hospital where high numbers of malaria and dengue are reported each 
year.  In this study, the data collected from 2012 until 2014 shows the high 
prevalence numbers of dengue infections within the regions of Tampin.  About 199 
patients were detected as being dengue-infected from year 2012 until 2014.  The 
confirmation of dengue virus serotype was finalized by patients' clinical history 
and dengue serology test.  From the molecular study, the results showed that 73 
patients, only 21 patients in 2012, 31 patients in 2013 and 21 patients in 2014 were 
positive with DENV 4.  were infected with dengue virus serotype 4 (DENV 4), 
according to the mukim in Tampin, Negeri Sembilan.   The absence of serotype 
DENV 1, DENV 2 and DENV 3 is unexpected which is due to the viability of the 
 xxi   
 
virus and the quality of the sample were affected by factors such as time, storage 
and transportation factors.  During this study, all patients’ blood film samples were 
examined as microscopic examination before proceeding to PCR test.  However, 
there is no incidence rate of malaria and filariasis reported over three years accept 
3 cases of malaria were reported as Plasmodium knowlesi.  The positive malaria’s 
patients were from Hutan Percha, Alor Gajah, Melaka (1 patient) and Johol, Kuala 
Pilah, Negeri Sembilan (1 male and 1 female). 
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CHAPTER-1 
 
 
 
 
INTRODUCTION 
 
 
 
 
 Vector-borne diseases are considered important diseases and have great 
impact on the health of humans and animals as well.  They are among the leading 
causes of worldwide mortality amounting to millions of cases. Approximately, half the 
world’s population is infected with at least, one type of Vector-borne disease every 
year and millions of people die of this each year.  Pherez (2007) reported that 
Vector-borne infections (VBI) were described in the year 1877 when lymphatic 
filariasis was transmitted by mosquitoes from human to human. However, several 
vector-borne infections have been described for the past 128 years, involving a variety 
of infectious pathogens, together with a wide range of cold-blooded (exothermic) 
arthropods which are sensitive to climatic factors.  
 
 Reproduction rates of vectors and weather influences survival, which in turn 
influencing habitat suitability, distribution and abundance of mosquitoes. 
Environmental factors also affect intensity and temporal pattern of vector activity 
(particularly biting rates) together with reproduction of pathogens within vectors 
throughout the year. However, climate is only one of many factors influencing vector 
distribution. Other important factors such as habitat destruction, land use, pesticide 
application, and host density could also play a major role in its distribution (Semenza 
and Menne, 2009). 
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   Vector-borne diseases (VBD) have become a major health problem affecting 
urban and pre-urban areas in tropical and subtropical regions around the world. These 
diseases also cause significant economic losses in regard to animal trade, agriculture, 
health care, tourism, as well as the destruction of ecosystems throughout the world. 
Therefore, vector-borne diseases can be controlled and prevented by both the 
economic community and individual. However, the infectious diseases behave within 
the constraint of natural biological systems with the rapid change from origin and 
physical environments seen today. Human interactions also play the role within these 
large systems compare to the changes of the nature of physical systems (WHO, 2014).  
 
 The spread and emergence of vector-borne diseases in Tampin District is a 
complex interplay among the pathogen, the host, and the environment. One key 
aspect needed to be studied is the distribution of VBD cases in Tampin district 
population, which is considered as one of the red areas and highest number of dengue 
and malaria cases in Malaysia (JKNNS, 2010, Ministry Of Health, 2011).  New data 
on VBD epidemiology studies is sorely needed as this will definitely help us to 
construct an effective disease management to control the spreading of the disease.   
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1.1 Problem Statement 
 
 
 
 Each element that plays a major role in the spreading of the VBD has equal 
important because each one relies on the other which is described in Diagram 1.0. A 
successful strategy for the control of such diseases is not through solely vaccinating 
and treatment of infected patients but through the reduction in the source of 
infection, which is often by the treatment of mosquitoes and other vectors. The 
ability to effectively control the vectors is only possible through extensive 
knowledge of biology bionomics and the behaviour of those vectors.  The 
population in Tampin District is at risk when the vector-borne disease becomes a 
problem where complaints of severe illness arises and that is when the transmission is 
taking place.  
 
 Therefore, it is important to look at the immediate environment of the 
population at risk to determine how people and communities can protect themselves. 
There are many things that can be done at the individual level to protect oneself from 
this disease. Nevertheless, many people do not take personal protection from being 
bitten by vectors. Their chances of getting infected is increased, in additional to the   
pathogen establishing itself in the community. This study will examine the prevalence 
of vector-borne diseases in Tampin District Hospital and will specifically investigate 
the correlation if the infections between socio-economic, demographic variables and 
environmental.   
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1.2 Research objectives 
 
 1.2.1 General Objective 
To determine the major prevalence of vector-borne diseases in          
Tampin District Hospital     
  
   1.2.2 Specific Objective     
  1.2.2(i) To determine  the  high prevalence of main vector borne 
diseases in Tampin District Hospital       
         1.2.2(ii) To  identify  environmental  factors  that  contribute to the  
                prevalence of vector-borne diseases  
          1.2.2 (iii)To understand how specific demographic  and  socioeconomic  
                status variables relate to vector-borne disease transmission 
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CHAPTER-2 
 
 
 
 
LITERATURE REVIEW 
 
 
 
 
2.1 Vector Borne Disease 
 
2.1.1Introduction 
 
 Vector-borne diseases are illnesses caused by pathogens and parasites carried by 
insects acting as vectors in the human population, causing morbidity and mortality. Most 
tropical and subtropical areas are represented with vector-borne diseases which is 
regarded as a major public health concern but the   threat is more serious in developing 
countries.  There are more than 1 billion cases and over 1 million deaths from at least 
one type of vector-borne disease every year (WHO, 2005).  This is because nearly 82 % 
of the global population live in areas at risk from one vector-borne disease with over half 
living in areas at risk of two or more of the major vector-borne diseases.  Some parts of 
sub-Saharan Africa, South Asia, and the Americas are at risk from five or more major 
vector-borne diseases and shows in the geographic distribution of the major vector-borne 
diseases (Figure 2.1) (Golding et al., 2015). 
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Figure 2.1: Combined global distribution of major vector-borne diseases (Golding et al., 2015) 
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  Vector-borne diseases account for over 17% of all globally infectious 
diseases such as malaria, dengue, yellow fever, and filariasis. In 2014, the WHO or the 
World Health Organization in Geneva, highlighted the serious and increasing threat of 
vector-borne diseases, with the slogan “Small bite, big threat” (United Nations in Loa 
PDR, 2014).  These disease outbreak are determined by the complex dynamics of 
environmental factors such as climate, temperature, rainfall and humidity as well as 
social factors such as community, movement of people, housing and others (Huang 
et.al, 2012).  
 
  Malaria is the most deadly vector-borne disease which has caused around 
627,000 deaths in 2012, mostly African children under the age of five. An estimated 
90% of annual global malaria deaths occur especially in sub-Saharan Africa.  
Approximately, 3.4 billion people at risk and the transmission occurs in 97 countries, 
around the world (WHO, 2013). Whereas, dengue is the world’s fastest growing 
vector-borne disease especially when it’s in the form of dengue hemorrhagic fever 
(DHF) (WHO, 2012).  Lately, dengue is endemic in more than a hundred countries in 
five out of the six WHO regions and about 2.5 billion people living in 
dengue-endemic countries (Su et al., 2016). Currently, estimates there may be 50–100 
million dengue infections worldwide every year which reported by WHO in 2013. 
 
 Despite malaria and dengue infections, lymphatic filariasis is another 
common vector-borne disease which has affected about 120 million people worldwide 
in 80 countries.  About 40 million of them are disfigured and incapacitated by the 
disease.  Approximately,  65%  of those infected live in the WHO South-East Asia  
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Region, 30% in the African Region, and the rest in other tropical areas (WHO, 2013). 
 
2.1.2 Transmission of Vector-borne diseases in Malaysia 
 
  Malaysia lies in a tropical climate area, and thus often has vectors (especially 
mosquitoes) which are capable of transmitting serious diseases like malaria, dengue, 
filariasis, Japanese Eencephalitis and others. The strategy to control these diseases is 
not by chemotherapeutic, but through the reduction in the source of infection of the 
disease (WHO, 2014).  The ability to control the vectors effectively is only possible 
through extensive knowledge in biology and the behavior of those vectors.  
Vector-borne diseases are still responsible for the high incidence of morbidity and 
mortality in many tropical countries, including Malaysia.  The burden of main vector 
borne diseases is shown in Table 2.1. (MOH, 2014). 
 
Table 2.1 : The type of diseases , prevalence and the morbidity of diseases in  
          Malaysia (MOH, 2016 and WHO, 2016) 
  
 
 
 
 
TYPE OF 
DISEASE/ 
POPULATION 
OF 100,000 
PREVELANCE/INCIDENCE 
2012 2013 2014 2015 
Incidence 
Rate 
Mortality 
Rate 
Incidence 
Rate 
Mortality 
Rate 
Incidence 
Rate 
Mortality 
Rate 
Incidence 
Rate 
Mortality 
Rate 
Dengue 76.0 0.16 145.9 0.21 361.1 0.20 396.4 0.28 
Malaria 16.11 0.05 1.30 0.01 13.03 0.03 7.58 0.03 
Filariasis 0.27 0 0.60 0 0.047 0 0.17 0 
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 The transmission of vector-borne disease is a challenging task to control 
because the diseases show complex dynamics impacted by a wide range of ecological 
factors (Xue, 2013). In Malaysia, dengue is the highest infected disease among the 
population and causes high mortality compared to malaria and filariasis (MOH, 
2012).  
 
   The data from Table 2.1 shows the highest incidence rate and mortality rate 
of vector-borne disease within 4 years from the year 2012 to 2015 was dengue. 
Malaysia also experienced the global increase of dengue incidence.  At total of 
45,466 cases were reported which is equivalent to incident rate of 145.9 cases per 
100,000 populations in year 2013 whereas the incident rate was inclined in year 2014 
and 2015 from 361.1 to 396.4 (cases per 100,000 populations) and the mortality rate 
were 0.20 to 0.28.  Therefore, dengue is the most common endemic vector-borne 
disease which is known as an endemic infective disease in Malaysia.  
 
   The first case of dengue fever outbreak in Malaysia was reported in 1962 
from Penang. Eventually, the first major outbreak of dengue hemorrhagic fever (DHF) 
in Malaysia occurred in 1973 and the country experienced a large epidemic with 3006 
notified cases with 35 deaths in 1982 (Rose, 2015). Dengue infection poses a great 
threat to the local inhabitants in Malaysia due to rapid increase in population and 
industrialization in the past few decades (Nadeem and Shamala, 2006). According to 
Jihoo et al., (2015), dengue cases recorded increased from 7,103 cases in 2000 to 
108,698 in 2014, with 215 deaths, and not less than 31,500 notified cases in any given 
year.  The dengue incidence in Malaysia continues to increase from 32 cases per 
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100,000 population to 361 cases per 100,000 population in 2014 and declined in 2015.  
This shows that Malaysia is one of the worstly affected country which has witnessed 
the highest number of dengue infection cases with significant raise from 2014 to 2015 
(Figure 2.2 and Figure 2.3).   
 
  However, the current status of dengue infections in Malaysia until October, 
2016 is 87,890 cases with 202 deaths compared to 21900 cases with 35 deaths in 2012, 
43346 cases with 92 deaths in 2013, 108,698 cases with 215 deaths in 2014 and 
120,836 cases with 336 deaths in 2015 as shown in Figure 2.2 (Ministry of health, 
2016). A recent increase in dengue incidents is a significant cause for concern, 
especially given the hyperendemicity of serotypes. According to the Ministry of 
Health (2015), the reason for the rise in the number of cases and deaths is the dengue 
serotype shift in August, 2014. There was a shift in the dominant serotype from 
DENV 2 to DENV 1. Other factors contributing to the increase in the number of 
dengue cases were environmental factors, uncontrolled human movements especially 
those humans carrying the virus, the weather and unhealthy human behavior.  Most 
of the dengue cases reported were from urban areas (70%–80%) where factors such as 
high density population and rapid development favour dengue transmission 
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Figure 2.2 : The comparison of total number of dengue cases in Malaysia from  
          1995 to 2015 (MOH, 2016)    
 
 
 
 
 
 
 
 
 
 
 
 
 
Year 
N
u
m
b
e
r 
 
O
f 
 
C
a
s
e
s 
Malaysia 
Dengue Cases 
13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 : The total cases of dengue deaths in Malaysia from 1995 to                           
          2015 (MOH, 2016)    
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   Table 2.2 shows the number of dengue cases and mortality which was 
reported according to states from 2013 to 2015 (Ministry of Health, 2016). The recent 
data shows Selangor has the highest number of dengue cases, followed by Johor, WP 
Kuala Lumpur & Putra Jaya, and Perak compared to other states. Other states such as 
Sabah, Kedah, Pahang and Penang also showed increasing in the dengue cases as well 
as death cases.   
 
   The number of dengue cases in Negeri Sembilan in 2013 was lowest 
compared in year 2014 and 2015. During this period, there were 1323 cases of dengue 
infections reported from Negeri Sembilan compared to 3781 cases in year 2014 and 
2454 cases in 2015.  But the number of death cases was the highest in 2015 and 
shows increasing from 2013 to 2015 in Negeri Sembilan if compare in year 2009 (5 
deaths) and 2010 (7 deaths) (JKNNS, 2010).  Table 2.3 shows the number dengue 
cases according to districts in Negeri Sembilan. The number of cases of Dengue 
Hemorrhagic Fever was the highest in 2010 compared to subsequent years.  After 
the year 2010, the dengue cases were decreasing in Negeri Sembilan compared to 
others states in Malaysia (MOH, 2015).   
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Table 2.2 : The number of dengue cases and death(s) reported from 2013 until                     
     2015 ( MOH, 2016). 
 
STATE 2013 2014 2015 
CASES DEATH CASES DEATH CASES DEATH 
PERLIS 
 
230 1 317 0 258 1 
KEDAH 833 1 1014 7 1000 14 
PENANG 1094 7 3141 11 5830 19 
PERAK 7525 21 2648 4 9466 25 
SELANGOR 26260 24 54290 77 63,198 127 
WP KL & PUTRAJAYA 2664 8 7185 21 8332 34 
N.SEMBILAN 1323 1 3781 10 2454 16 
MELAKA 1549 9 2770 6 2420 8 
JOHOR 4977 27 6323 25 15,743 51 
PAHANG 744 2 2170 6 3001 16 
TERENGGANU 1688 2 621 0 1455 5 
KELANTAN 1454 2 14456 17 2850 7 
SARAWAK 1311 4 2571 6 1923 3 
SABAH 744 6 1456 6 2904 10 
WP LABUAN 14 0 11 0 2 0 
TOTAL 45466 96 108698 215 120836 336 
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District 2009 2010 (+/-) 
Cases % 
SEREMBAN 524(5) 1132(5) 608 +160 
KUALA PILAH 18 22 4 +22.2 
PORT DICKSON 67 82(2) 14 +20.9 
JEMPOL 28 53 25 +89.3 
JELEBU 19 11 -8 -42.1 
TAMPIN 14 48 34 +242.9 
REMBAU 26 31 5 +19.2 
NEGERI SEMBILAN 696(DF:619, 
DHF:77) 
5 DEATH 
1378(DF:1266, 
DHF:112) 
7 DEATH 
+682 +98.0% 
 
 
 Even though dengue is the highest prevalence of vector-borne diseases in 
Malaysia, but currently, malaria is also shows the most important vector-borne 
diseases, primarily in Malaysian Borneo (Sarawak and Sabah states), although only 
4% of the population is living within active malaria transmission foci areas.  
Malaysia has battled malaria for most of its recent history. Post-World War II reports 
show upwards trend of 300,000 cases treated annually (inpatient and outpatient) in 
West Malaysia alone (WHO, 2015). Infection rates remained high through the 1950s 
and 1960s with more than 200,000 reported cases in 1961.  
 
 The Global Health Group and WHO (2014) reported that Plasmodium vivax 
(2,422 cases, 45.6%) and P. falciparum (973 cases, 18.3%) were responsible for the 
majority of malaria cases in Malaysia, closely followed by P. malariae (903 cases, 
17.0%) and P. knowlesi (854 cases, 16.1%), which together represent a substantial 
proportion of cases in Sabah and Sarawak in 2011.  However, the incident rate of 
Table 2.3 : Dengue cases in  Negeri Sembilan   according  to    districts                    
         (JKNNS, 2010) 
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malaria declined to 18.6 per 100,000 population in 2011 from 318.6 per 100,000 in 
1980.   
 
  Figure 2.4 shows the number of malaria cases by species in Malaysia from 
1997 until 2011. In 2011, Plasmodium vivax (2 422 cases, 45.6%) and P. falciparum 
(973 cases, 18.3%) were responsible for the majority of malaria cases in Malaysia, 
closely followed by P. malariae (903 cases, 17.0%) and P. knowlesi (854 cases, 
16.1%), which together represent a substantial proportion of cases in Sabah and 
Sarawak. This is in contrast to parasitological trends in 1992, at which time P. 
falciparum made up 65.1% of reported cases, while P. vivax contributed 31.6%. As a 
result, Plasmodium falciparum cases were declining from 1997 until 2011, whereas 
Plasmodium knowlesi cases were first reported in 2008 (WHO, 2015).  
   
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 2.4 : Malaria cases by species in Malaysia from 1997 to 2011 (WHO,2015) 
 
Figure 2.2 : Malaria cases by species in Malaysia from 1997 to 2011 (WHO,2015) 
Year 
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  One of the main contributing factors for higher infection of malaria in 
Malaysia is the presence of the large number of migrant workers. About 21.9 per cent 
of malaria cases in Malaysia were imported which was reported in 2011 (MOH, 2011).  
Most of these foreigners came from malaria-endemic countries, a majority from 
Indonesia (68.9%), followed by Nepal (9.9%), India (6.9%) and Myanmar (4.6%) 
since 2005 (WHO, 2015).  
 
  Lately, Malaysia’s National Strategic Plan for the Elimination of Malaria 
(NSPEM) is pursuing spatially-progressive malaria elimination and has set a goal of 
nationwide elimination by 2020. The Ministry of Health (2016) has reported that the 
potential threats and challenges to the elimination includes the importation of cases 
from malaria-endemic neighboring countries, especially the multi-drug resistant 
strains from Myanmar, Indonesia and Thailand.  Figure 2.5 and Figure 2.6 show the 
number of malaria cases in Malaysia and Negeri Sembilan.  From year 2010 to 2012 
is showing declined in number of malaria cases accept 2014 showed slightly 
increased but number of death cases are decreased from year to year.  A total of 9 
deaths were reported in year 2014, which is a reduction of 74% compared to year 
2000 (35 deaths) (MOH, 2015).  
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Figure 2.5 : The number of malaria cases and the incident rate in Malaysia from       
         2010 to 2014 ( MOH, 2016) 
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 Figure 2.6 : The number of malaria cases in Negeri Sembilan from 2010 to 2014 
           (MOH, 2016) 
 
 
      A study done by Timothy and Jayaram (2014) between September, 2012 and 
December, 2013, has shown that P. knowlesi was identified in 256 (56.5%) cases, 
followed by 133 (29.4%) cases of P. vivax, 49 (10.8%) cases of P. falciparum, two 
(0.4%) cases of P. ovale and one (0.2%) case of P. malariae. Twelve mixed infections 
were detected, including P. knowlesi and P. vivax (10 cases), P. knowlesi and P. 
falciparum (1 case), and P. falciparum and P. vivax (1 case). P. knowlesi (including 
mixed infections involving P. knowlesi (P. knowlesi/P. vivax and P. knowlesi/P. 
falciparum) showed the highest proportion in Sabah (84/115 cases, prevalence of 
73.0%), Sarawak (83/120, 69.2%), Kelantan (42/56, 75.0%), Pahang (24/25, 96.0%), 
Johor (7/9, 77.8%), and Terengganu (4/5, 80.0%). However, P. knowlesi infections in  
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Selangor and Negeri Sembilan were found to be 16.2% (18/111 cases) and 50.0% 
(5/10 cases) of national figures respectively and shown in Table 2.4. 
 
Table 2.4 : The Number of Plasmodium knowlesi cases and its prevalence 
 
 
   Lendrum et al., (2016) reported that approximately, more than one billion 
people are infected and more than one million deaths from malaria and dengue every 
year.  In addition, lymphatic filariasis also cause significant debilitation and suffering 
in most infected people.  During the years 1988 to 1990, there appeared to be a 
decreasing trend in the number of filariasis cases detected countrywide that every year.  
In 1991, Brugian filariasis accounted for 92% of the cases detected (Marzuki et al., 
1993). 
 
    In Malaysia, the prevalence of lymphatic filariasis has decreased by 41.3% 
since 1990. This was reported annually with an average of 1.8% a year (WHO, 2015). 
According to Nazeh et.al., (2014), the WHO organized the ‘Global Programme’ in 
1997, to eliminate the Lymphatic Filariasis as a public health crisis by the year 2020, 
mainly through the institution of annual mass drug administration (MDA) programs 
for people living in endemic areas.  In addition to interrupting the transmission, mass 
drug administration (MDA) such as diethylcarbamazine and albendazole, provides 
No. States Cases Plasmodium knowlesi 
or mixed infection 
Prevalance 
(%) 
1. Sabah 115 84 73.0 
2. Sarawak 120 83 69.2 
3. Kelantan 56 42 75.0 
4. Pahang 25 24 96.0 
5. Johor 9 7 77.8 
6. Terengganu 5 4 80.0 
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significant collateral health benefits, to reduce morbidity from intestinal worms and 
ecto-parasites (WHO, 2010).  
 
  Filariasis infestation is endemic in 8 states such as Kedah, Perak, Johor, 
Pahang, Terengganu, Kelantan, Sabah and Sarawak. The National Lymphatic 
Filariasis Elimination Program under the Ministry of Health with the collaboration of 
the World Health Organization has given special attention to all these states by 
stopping the transmission of filariasis and controlling the morbidity of lymphatic 
filariasis patients (MOH, 2016).  The number of filiariasis infected cases raised in 
1996 and is shown in Figure 2.6 (MOH, 1996).  Five local Malaysian patients with 
clinical manifestations consistent with lymphatic filariasis were found between 2003 
and 2006 (Lian et al., 2010). 
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  Nevertheless, in 2011, the total number of filariasis were 387 cases which 
was increased number of cases (148%) compared to the previous year (156 cases). 
Filariasis cases increased in 2011 was influenced by increased activity in active case 
detection in which total of night blood sample slides were increased by 30% over 
2010. In 2011, the incidence rate of filariasis was 1.36 per 100,000 population.  
However, the microfilaria rate for the last 5 years ranges from 2.14 to 1.41 per 1000 
people. Out of 387 total cases, 201 cases (52%) are detected among local and 186 
cases (48%) are detected among immigrant. 
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Figure 2.7 : The  number  of  Lymphatic Filariasis cases in Malaysia in 1992   
         to 1996 ( MOH, 1996) 
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In 2012, the prevalence rate of filariasis was 0.93 per 100,000 populations. 
The number of cases noted increase in year 2011 and 2012 as compared to 2010 due 
to increase detection of cases from survey activities in elimination programme. A total 
of 136 filariasis cases were reported in 2014, showing a 58% decrease from 321 cases 
in 2013.  In 2014, the prevalence rate of filariasis was 0.11 per 100,000 populations. 
Most cases (96%) were detected through Active Case Detection (ACD) from survey 
activities in elimination programmes. Out of 136 total cases, 18 cases (13%) are 
detected among locals and 118 cases (87%) are detected among immigrants. 
 
 
The predominant parasite species are Wuchereria bancrofti which contributes 
the highest if compare to Brugia malayi (periodic) and Brugia malayi (subperiodic) in 
those years.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8 – The number of filariasis cases with the incidence rate from year 2010 to   
           2014 (MOH, 2014) 
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